Heilongjiang Linbao Pharmaceutical Co., Ltd

Main study objectives To evaluate the pharmacokinetic characteristics and bioequivalence of aspirin enteric-coated tablets (specification: 100 mg, applicant: Heilongjiang Linbao Pharmaceutical Co., Ltd.) and reference preparation (trade name: Bayer Aspirin®, specification: 100 mg, licensee: Bayer S.p.A.) after a single oral dose in healthy Chinese adult subjects under fasting and postprandial conditions. Secondary study objectives To study the safety of aspirin enteric-coated tablets (specification: 100 mg) and reference preparation (trade name: Bayer Aspirin®, specification: 100 mg) in healthy Chinese adult subjects.